Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above
Clinical trial NCT04917523 · COMPLETED
Trial details
- NCT number
- NCT04917523
- Sponsor
- China National Biotec Group Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-02
- Primary completion
- 2022-03-31
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.